“BENEFITS OF PHARMACOTHERAPEUTIC FOLLOW-UP FOR THE TREATMENT OF PATIENTS WITH DIABETES MELLITUS: A INTEGRATIVE REVIEW”, RECIMA21, vol. 2, no. 9, p. e29726, Oct. 2021, doi: 10.47820/recima21.v2i9.726.